Suppr超能文献

外用药物成分接触性过敏:欧洲接触性过敏监测系统(ESSCA)2009 - 2012年的结果

Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009-2012.

作者信息

Uter Wolfgang, Spiewak Radoslaw, Cooper Susan M, Wilkinson Mark, Sánchez Pérez Javier, Schnuch Axel, Schuttelaar Marie-Louise

机构信息

Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany.

Department of Experimental Dermatology and Cosmetology, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.

出版信息

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1305-1312. doi: 10.1002/pds.4064. Epub 2016 Jul 28.

Abstract

PURPOSE

The aim of this study was to give an overview of the prevalence of contact allergy to active ingredients and excipients of topical medications across Europe.

METHODS

Retrospective analysis of data collected by the European Surveillance System on Contact Allergies (www.essca-dc.org) with substances applied to consecutively patch tested patients, 2009-2012, in 54 departments in 12 European countries.

RESULTS

In view of the varying composition of the baseline series used in the previously mentioned departments and countries, between 58 833 (lanolin alcohols) and 16 498 patients (sodium metabisulfite) were patch tested with the topical agents covered in this study. Among these, positive (allergic) reactions were most commonly observed to sodium metabisulfite (3.12% positive), followed by propolis (2.48%), Compositae mix (1.73%), lanolin alcohols (1.65%) and caine mix III (benzocaine, cinchocaine and tetracaine; 1.27%).

CONCLUSIONS

Several of the substances warrant routine screening for contact allergy, i.e. patch testing in a baseline series. However, in view of a vast number of other topical agents, additional patch testing with the suspect topical drug preparations (including natural remedies and cosmetics) is warranted. In the event of a positive test to the (pharmaceutical) product, single ingredients should be tested individually to precisely identify the hapten(s). Copyright © 2016 John Wiley & Sons, Ltd.

摘要

目的

本研究旨在概述欧洲范围内外用药物活性成分和辅料接触性过敏的患病率。

方法

对欧洲接触性过敏监测系统(www.essca-dc.org)收集的数据进行回顾性分析,这些数据来自2009年至2012年在12个欧洲国家的54个科室中连续接受斑贴试验的患者所使用的物质。

结果

鉴于上述科室和国家所使用的基线系列组成各异,本研究涵盖的外用制剂对58833名患者(羊毛脂醇)至16498名患者(偏亚硫酸氢钠)进行了斑贴试验。其中,对偏亚硫酸氢钠的阳性(过敏)反应最为常见(阳性率3.12%),其次是蜂胶(2.48%)、菊科混合物(1.73%)、羊毛脂醇(1.65%)和卡因混合物III(苯佐卡因、辛可卡因和丁卡因;1.27%)。

结论

几种物质有必要进行接触性过敏的常规筛查,即在基线系列中进行斑贴试验。然而,鉴于还有大量其他外用制剂,有必要对可疑的外用药物制剂(包括天然药物和化妆品)进行额外的斑贴试验。如果对(药物)产品的试验呈阳性,应单独测试单一成分以精确鉴定半抗原。版权所有© 2016约翰威立父子有限公司。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验